David Alexander

Title: David Alexander: Innovator in HIV-1 Vaccine Development

Introduction

David Alexander is a prominent inventor based in Santa Cruz, California. He has made significant contributions to the field of immunology, particularly in the development of vaccines against HIV-1. His innovative work focuses on creating effective immunogens that can elicit a strong immune response.

Latest Patents

David Alexander holds a patent for "Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp 120." This patent details the creation of HIV-1 vaccine immunogens based on glycopeptide scaffolds. These scaffolds contain sequences from the V1/V2/V3 and C3 domains of HIV-1 gp120, which are capable of binding multiple broadly neutralizing antibodies when expressed in mammalian cells that incorporate mannose-5 and mannose-9 glycans. He has 1 patent to his name.

Career Highlights

David Alexander is affiliated with the University of California, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding and treatment of HIV-1 through innovative scientific approaches.

Collaborations

Some of his notable coworkers include Bin Yu and Phillip Berman. Their collaborative efforts contribute to the ongoing research and development in the field of HIV-1 vaccine technology.

Conclusion

David Alexander's work in the development of HIV-1 vaccine immunogens represents a significant advancement in the fight against this virus. His innovative approach and dedication to research continue to inspire progress in immunology.